Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Daher-Reyes, Georgina | - |
dc.contributor.author | Kim, TaeHyung | - |
dc.contributor.author | Novitzky-Basso, Igor | - |
dc.contributor.author | Kim, Kyuoung Ha | - |
dc.contributor.author | Smith, Adam | - |
dc.contributor.author | Stockley, Tracy | - |
dc.contributor.author | Capochichi, Jose-Mario | - |
dc.contributor.author | Al-Shaibani, Zeyad | - |
dc.contributor.author | Pasic, Ivan | - |
dc.contributor.author | Law, Arjun | - |
dc.contributor.author | Lam, Wilson | - |
dc.contributor.author | Michelis, Fotios V. | - |
dc.contributor.author | Gerbitz, Armin | - |
dc.contributor.author | Viswabandya, Auro | - |
dc.contributor.author | Lipton, Jeffrey | - |
dc.contributor.author | Kumar, Rajat | - |
dc.contributor.author | Mattsson, Jonas | - |
dc.contributor.author | Schimmer, Aaron | - |
dc.contributor.author | McNamara, Caroline | - |
dc.contributor.author | Murphy, Tracy | - |
dc.contributor.author | Maze, Dawn | - |
dc.contributor.author | Gupta, Vikas | - |
dc.contributor.author | Sibai, Hassan | - |
dc.contributor.author | Chan, Steven | - |
dc.contributor.author | Yee, Karen | - |
dc.contributor.author | Minden, Mark | - |
dc.contributor.author | Zhang, Zhaolei | - |
dc.contributor.author | Schuh, Andre | - |
dc.contributor.author | Kim, Dennis D. H. | - |
dc.date.accessioned | 2021-09-10T06:45:37Z | - |
dc.date.available | 2021-09-10T06:45:37Z | - |
dc.date.issued | 2021-08 | - |
dc.identifier.issn | 0268-3369 | - |
dc.identifier.issn | 1476-5365 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/19348 | - |
dc.description.abstract | The impact of adverse risk genetic profiles on outcomes in acute myeloid leukemia (AML) patients following allogeneic hematopoietic stem cell transplantation (HCT) has not been fully elucidated. Accordingly, we have profiled somatic mutations at diagnosis using next-generation sequencing (NGS) in 178 AML patients who received allogeneic HCT. NGS revealed 598 somatic mutations in 165/178 patients (92.7%). Frequently mutated genes include DNMT3A, TET2, NPM1, RUNX1, IDH2, and FLT3. Commonly detected cytogenetic profiles include normal karyotype, trisomy 8, monosomal karyotype (MK), deletion 5, complex karyotype (CK), and monosomy 7. In univariate analyses, TP53 mutation, MK, CK, and monosomy 7 were associated with decreased overall survival (OS), relapse-free survival (RFS), and a higher relapse incidence (RI). We defined adverse molecular-genetic profile as harboring at least one of the molecular/genetic abnormalities of TP53 mutation, MK, CK, monosomy 7, and deletion 5. The patients harboring adverse molecular-genetic profile (n = 30) showed a lower 2-year OS (24.9% vs. 57.9%; p = 0.003), RFS (23.7% vs. 57.9%; p = 0.002), and higher RI (47.2% and 17.2%; p = 0.001) after HCT when compared to patients without those lesions. Multivariate analysis confirmed adverse molecular-genetic profile as an independent prognostic factor, associated with decreased OS (HR 2.19), RFS (HR 2.23), and higher RI (HR 2.94). | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Nature Publishing Group | - |
dc.title | Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1038/s41409-021-01255-4 | - |
dc.identifier.scopusid | 2-s2.0-85103180582 | - |
dc.identifier.wosid | 000632750500004 | - |
dc.identifier.bibliographicCitation | Bone Marrow Transplantation, v.56, no.8, pp 1908 - 1918 | - |
dc.citation.title | Bone Marrow Transplantation | - |
dc.citation.volume | 56 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1908 | - |
dc.citation.endPage | 1918 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Transplantation | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Transplantation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.